iX Syrinx is a member of the iX Biopharma Group (iX).
iX has a portfolio of products in the pipeline utilising our WaferiX® sublingual delivery system.
Oxford Journal on Pain Medicine, 2017
British Journal of Clinical Pharmacology, 2013
WaferiX® is a platform drug delivery technology which can be used to formulate off-patent generic drugs into a new dosage form with superior characteristics. These include improved absorption, faster onset of action and convenient administration. All of these provide market differentiation and prolong the product life cycle of off-patent drug.